Abstract | The classification and monitoring of individuals with early knee osteoarthritis (OA) are important considerations for the design and evaluation of therapeutic interventions and require the identification of appropriate outcome measures. Potential outcome domains to assess for early OA include patientreported outcomes (such as pain, function and quality of life), features of clinical examination (such as joint line tenderness and crepitus), objective measures of physical function, levels of physical activity, features of imaging modalities (such as of magnetic resonance imaging) and biochemical markers in body fluid. Patient characteristics such as adiposity and biomechanics of the knee could also have relevance to the assessment of early OA. Importantly, research is needed to enable the selection of outcome measures that are feasible, reliable and validated in individuals at risk of knee OA or with early knee OA. In this Perspectives article, potential outcome measures for early symptomatic knee OA are discussed, including those measures that could be of use in clinical practice and/or the research setting.
. OA is associated with increased rates of comorbidity (for example, obesity and heart disease) 1 and is one of the most burdensome disabilities worldwide 2 . The incidence, burden and socioeconomic impact of OA is considerable and growing 3, 5 . Therefore, a shift in the approach to the management of patients with OA is needed, from treating patients with established OA to a proactive approach that focuses on mitigating risk factors. The classification and monitoring of early OA, on a trajectory from normal to symptomatic and/or radiographic OA, would allow the development and evaluation of interventions in clinical and research settings to prevent or slow down make this approach increasingly viable. For example, widely used online prediction tools are now available for evaluating the future risk of osteoporotic fractures and for guiding clinicians in preventive management of osteoporosis [7] [8] [9] . Comparable reliable and validated outcome measures for early knee OA will inform the evaluation of risk factors for the progression of early OA. More than one set of risk factors and models will probably be needed to predict early OA in the future.
In the Rotterdam and Chingford studies (two prospective population-based studies), researchers were able to predict incident radiographic knee OA using a combination of clinical, genetic and radiographic factors 10 . When performing risk assessment and creating a predictive model for early knee OA, many aspects need to be considered: the definitions of the outcome and prognostic factors; the duration of the clinically relevant prediction period; and the setting in which the risk prediction tool will be used (for example, primary care, secondary care or the research setting). For instance, expensive and intensive predictive tools such as MRI scans and biochemical markers might be restricted to secondary care and/or the research setting.
In this Perspectives article, we highlight considerations for best practice in the selection of outcome measures for use in clinical practice and the research setting to evaluate patients at initial presentation of early knee OA across different outcome domains: patient-reported outcomes, clinical features, physical function outcomes, modifiable lifestyle-related outcomes (such as adiposity, physical activity and nutrition), biomechanical outcomes, imaging features and biochemical markers 11 . We suggest outcome measures that could be considered for use in individuals with early knee OA in clinical care and the research setting using published evidence (primarily from populations with post-traumatic and established OA), emerging evidence (ongoing studies) and clinical expertise (Box 1). The outcome measures highlighted are relevant to individuals who are at risk of OA or fit the provisional criteria for early knee OA based on patient-reported outcomes of pain and function, together with clinical signs (joint line tenderness or crepitus (that is, grating the disease process at a time the disease is probably more amenable to modification.
Although the definition of early OA and appropriate outcomes are under development, OA is probably heterogeneous in terms of its presentation and progression. Knee OA might progress slowly over a period of 10 or more years, rapidly or not at all 6 . Predicting the development and progression of the disease through identifying risk factors and mechanisms of OA is important in the management of chronic disease to inform targeted prevention and treatment strategies. Such prediction is difficult because of the heterogeneous presentation of OA; however, the availability of increasingly sophisticated statistical and computational methods, microsimulation modelling and large population-based cohort studies and crackling sounds)) and a radiographic Kellgren-Lawrence (KL) grade of 0 or 1 (ref.
12
). Although proposed as important evidence-informed clinical outcome measures, these outcome measures will require additional validation and possible modification to suit local primary-care and other health-care settings, as well as periodical updates.
Patient-reported outcomes
A patient-reported outcome is any patient health status that is reported directly by the patient without interpretation by others (for example, the clinician). Measures of these outcomes commonly take the form of a questionnaire. Most relevant patient-reported outcome measures have been developed to assess individuals with either a knee injury (for example, International Knee Documentation Committee 2000 (IKDC2000)) or established OA (for example, the Western Ontario and McMaster Osteoarthritis Index (WOMAC)), although one questionnaire has been developed to cover the full spectrum of OA from injury to established OA (the Knee Injury and Osteoarthritis Outcome Score (KOOS)). The relative merits of these and other available instruments that measure self-reported pain, function and quality of life have been the subject of previous reviews 13, 14 . Other patient-reported outcome measures, such as the Patient-Reported Outcomes Measurement Information System (PROMIS), have been developed using computer-adaptive strategies and might also prove relevant for use in people with early knee OA 15 . Many of the considerations that influence the choice of measure in established OA (for example, respondent burden, cost or availability) apply also in early OA.
Ultra-brief (1 or 2 domains) unidimensional generic measures, such as the 11-point Numerical Rating Scale (NRS) and the 36-item Short Form Health Survey (SF-36) bodily pain scale, have been previously recommended for established OA 16 and are probably also applicable in early OA. However, the disadvantage of unidimensional measures is that they provide a restricted view of the character and intensity of the pain 16, 17 , which is probably inappropriate based on emerging evidence from qualitative studies in patients with early knee OA [18] [19] [20] . For instance, these patients report that their initial symptoms can be experienced as an 'awareness' of the knee, loss of confidence or the need to 'be careful' , as opposed to 'pain' . Furthermore, reporting OA pain as 'constant' or 'present on most days' might lead to floor effects (that is, most individuals might have scores at the lower end of the scale) in early OA, as these patients often report episodic and intermittent pain with certain activities. For example, data from the Osteoarthritis Initiative indicate that pain during ascending or descending stairs is most likely to be the earliest reported functional difficulty 21 . Accordingly, the knee-related quality of life subscale of KOOS considers various pain-related aspects of early OA (such as awareness of a knee problem or loss of confidence in the knee) 14, 15 , and the Intermittent and Constant Assessment of Pain (ICOAP) questionnaire includes a subscale for intermittent pain symptoms 22 . The ICOAP questionnaire was designed to evaluate the pain experience of individuals with OA, and there is an increasing amount of evidence supporting its reliability and validity 22 . This questionnaire considers pain intensity, frequency and the impact of pain on mood, sleep and quality of life, and is intended to be used alongside a measure of physical function 22 . By contrast, the KOOS was developed for self-reporting of patient-relevant outcomes across the lifespan, from the time of knee injury and potential knee OA onset to severe OA [23] [24] [25] [26] . In five separate subscales, this tool assesses perceived pain and other symptoms (for example, stiffness, grinding and catching), perceived difficulty with function during daily life, sport and recreational activities, voLUme 15 | JULY 2019 | 439 NATURe RevIewS | RHEuMATOlOgy P e r s P e c t i v e s Box 1 | Proposed outcomes for the assessment of early pre-radiographic OA Below, we provide suggestions for outcome measures that could be used to assess individuals with early pre-radiographic osteoarthritis (oA) in clinical practice and in the research setting. many of these measures have been evaluated primarily in established oA 42, 43, [46] [47] [48] [49] [56] [57] [58] 65, 152 ; thus, further research is needed to evaluate the validity of each outcome measure in early oA and to investigate how outcomes change with progression of oA.
In clinical practice and research settings:
• Patient-reported outcomes The Knee Injury and osteoarthritis outcome Score (KooS) can be used to measure pain during activity, other symptoms (for example, stiffness, grinding, catching, swelling, knee flexion and extension), function in daily life and during sport and recreational activities, and quality of life across different age and treatment groups. The Intermittent and Constant Assessment of Pain (ICoAP) questionnaire can be used to evaluate constant and intermittent pain.
• Clinical features A clinical assessment including joint line tenderness should be performed in individuals with new-onset symptoms of knee pain, stiffness, crepitus or a feeling of 'giving way'.
• Physical function outcomes Three measures seem promising for use in the clinical setting on the basis of their reproducibility, patient acceptability and the equipment 152 and expertise required: the single leg hop test 42, 43, [46] [47] [48] [49] , the 30-second chair sit-to-stand test [56] [57] [58] , the star excursion balance test 43, [50] [51] [52] [53] [54] [55] and measures of quadriceps strength 43, 46, 47, 51, 65 . multiple additional functional measures have been validated for use in the research setting.
• modifiable lifestyle-related outcomes Adiposity can be assessed by measuring body fat percentage or fat mass index (fat mass in kilograms/height in metres squared) using dual-energy X-ray absorptiometry or bioelectrical impedance analysis if available. BmI is more feasible in the clinical setting, although it has limitations for use in athletes. Levels of physical activity can be assessed using a validated physical activity monitor or a validated questionnaire if objective methods are not available. Nutrition outcomes are not currently suggested for use in routine clinical care; however, the 3-day dietary record provides reliable estimates of nutrient intake.
In research setting only:
• Biomechanical outcomes measures of biomechanical outcomes require further research and are not currently suggested for use in routine clinical care. However, such outcomes are ideal for informing the underlying mechanisms of oA progression and informing treatment interventions in the research setting.
• Imaging features The utility of plain radiography in early oA is limited. Although mRI has superior sensitivity to change, has validity in the context of early oA 152 and is hence ideal in the research setting, mRI is not thought appropriate for the routine clinical care setting because of its high cost and potential risk of over-diagnosis.
• Biomarkers No biomarkers are currently of use in routine clinical care; however, further validation of proteomic, lipidomic and metabolomic tools in the research setting could lead to informative cartilage and synovial fluid profiles and provide important insights into oA progression.
and knee-related quality of life. The measurement properties of KOOS have been reported in studies of young, middle-aged and elderly groups with knee injury or OA, and across a spectrum of treatments 14 . A comprehensive literature review, which included 37 studies evaluating KOOS measurement properties in participants with knee injuries and/or OA, showed that KOOS has adequate content validity, internal consistency, test-retest reliability, construct validity and responsiveness for age-relevant and condition-relevant subscales 14 . The KOOS is feasible to administer electronically and in paper form, and KOOS scoring instructions and population-based KOOS reference data are available. In addition, longitudinal KOOS data have been collected from >100,000 patients in surgical registries of anterior cruciate ligament (ACL) reconstruction and knee replacement, facilitating comparison with many different populations 27, 28 . Furthermore, KOOS data from the Osteoarthritis Initiative cohort, which consists of individuals who are at increased risk of OA or who have established OA, are freely available (see Related links). The Osteoarthritis Initiative also collects a wide range of other self-reported, clinical and imaging data.
Another important consideration for outcome measures of OA is that the early phase of knee OA is often associated with the emergence of adaptive behaviour. Symptom frequency and intensity might be minimized through the selection of behaviours (for example, performing some activities less often), optimization of behaviours (for example, advanced planning of activities, including anticipatory analgesic use) and compensatory adaptations (for example, modifying the way activities are performed) 29 . Therefore, adaptive behaviour is an important consideration for outcome measures in early OA 30 . For example, the Questionnaire to Identify Knee Symptoms (QuIKS) includes questions such as "I am considering stopping a favourite activity due to my knees" and "I am considering changing my exercise routine due to my knee problems" 31 . OA-specific measures developed for more advanced OA cannot be assumed to have adequate psychometric performance when applied to early OA. Yet, the requirement for adequate performance in early OA must be balanced against the benefits for a coherent evidence base that comes from using common measures across the spectrum from early to advanced OA. Of the existing measures, the KOOS and ICOAP questionnaire seem to best strike this balance and are therefore strong candidates for evaluating early knee OA (Box 1), particularly as these instruments focus on different aspects, and both have the advantage of being freely available. Published reviews of the psychometric properties of these two measures require systematic updating with specific attention to their performance in early OA.
Clinical features
Clinical features of early OA, such as joint tenderness and crepitus, are easy to examine in the primary-care setting, and their assessment is also relevant in the research setting. These measures might be associated with the development of OA in the future, even in the absence of radiological findings of OA (Box 1). For example, joint line tenderness (of the tibiofemoral and/or patellofemoral joint lines) at baseline was found to be a strong predictor of pain progression at 5 years (moderate progression adjusted OR = 3.9, 95% CI 2.3-6.6) 32 in the CHECK cohort, which included patients with new-onset knee pain or stiffness 33 . Several studies have evaluated the ability of physical signs to predict the clinical onset of structural radiographic OA in patients with an increased risk of OA [32] [33] [34] [35] [36] . Data from the HONEUR study, which included 549 participants who were recruited at the first presentation of knee pain in primary care, suggest that joint line tenderness, crepitus, pain with passive flexion and a self-reported swollen knee predict incident radiographic tibiofemoral knee OA after 6 years 34 . Using MRI features of knee OA as an outcome, data from the Rotterdam Study show that joint line tenderness together with the 'feeling of giving way' are associated with the incidence of tibiofemoral knee OA, but identify crepitus as a good predictor of patellofemoral OA 35, 36 . Clinical examination of the knee (including joint line tenderness and crepitus) has good inter-observer reliability in patients with evident knee OA if a standardized approach to the assessment is used 37 . However, the various components of such examinations require further assessment for their reliability and validity in the research setting and standardization for use in the clinical setting for early knee OA.
Physical function outcomes
Given that the early pre-radiographic stage of OA is associated with intermittent symptoms and adaptive physical behaviour, the clinical evaluation of patients with, or at risk of, early knee OA should incorporate robust outcome measures of physical function 38 . Currently, no consensus exists regarding which outcome measures are most relevant for use in this population. For the purposes of this Perspectives article, physical function is operationally defined as 'physiological functions' or 'the ability to move around and to perform daily activities' that can be classified as 'body functions and structure' or 'activities and participation' , respectively, using the WHO International Classification of Functioning, Disability and Health (ICF) model 39 . As physical function is multidimensional, both performance-based and physical impairment measures (which might require specialized equipment and raters) are discussed in this section. Emerging evidence suggests that some of these outcome measures might be suitable for the evaluation of patients with early OA and individuals at risk of OA [40] [41] [42] [43] [44] [45] (TaBle 1) .
A range of performance-based measures are available, although the degree to which their measurement properties (such as their reliability and validity) have been tested and the range of populations they have been tested in vary (TaBle 1) . Performance-based measures that have undergone fairly extensive investigation include the single leg hop for distance test 42, 43, [46] [47] [48] [49] , the cross hop for distance test 42, [46] [47] [48] [49] , the 6-metre timed hop test 42, [46] [47] [48] [49] , the star excursion test (and the similar Y-balance test) 43, [50] [51] [52] [53] [54] [55] , the 30-second chair sit-to-stand test [56] [57] [58] and the 6-minute walk test 40, 41 . However, some data are now also available for the vertical drop jump test 43, 59 , the single leg squat test 43, [60] [61] [62] , the unipedal dynamic balance test 43, 63 and the 20-metre shuttle run test 43, 64 . The most commonly reported outcome of physical impairment is quadriceps muscle strength 43, 46, 47, 51, 65 , but there might also be value in considering the strength of other muscles of the lower extremities, including the hamstring, hip abductor and hip adductor muscles 66 . However, insufficient information is available to advocate a specific mode of contraction (that is, isotonic, isokinetic or isometric) or type of contraction (that is, concentric or eccentric) to assess.
Because of floor and ceiling effects, separate measures are required to cover the wide range of ages and abilities of patients with early knee OA in both the clinical and the research settings. Functional outcome measures that should be considered for use in research and in clinical physical and exercise therapy practice, on the basis of their measurement properties and ability to span the full spectrum of patient ages and abilities, include the single leg hop test for distance, the 30-second chair sit-to-stand test, the 6-minute walk test, the star excursion balance test and a quadriceps strength measure. Performance-based outcome measures should be performed in a standardized, validated and reproducible manner to enable detection of change over time. Video demonstrations and detailed instructions for standardized testing are available online (see Related links). Further research validating functional outcome measures in 'at-risk' populations (such as individuals with obesity, an intra-articular knee injury or a varus or valgus malalignment) and 'early-OA' populations is required, and should inform the periodic updating of these suggested functional outcome measures.
Modifiable lifestyle-related outcomes Modifiable risk factors related to lifestyle, such as obesity, dietary inadequacies and physical inactivity, might accelerate disease onset and progression through a combination of mechanical and systemic mechanisms 67 . Identifying these modifiable risk factors in individuals with early knee OA is important for the prevention of OA.
Several measures of adiposity or weight have been studied in established OA, but less so in early OA. These measures include BMI, waist-to-height ratio and waist circumference [68] [69] [70] [71] [72] . In addition to contributing to an increased mechanical load, adiposity is thought to have a metabolic and pro-inflammatory function in OA; therefore, a direct measure of adiposity, such as fat mass, percentage of fat mass (percentage of total mass) and fat mass index (fat mass in kilograms/ height in metres squared), for example, through the use of dual-energy X-ray absorptiometry or bioelectrical impedance analysis 73 , might be useful in the assessment of early OA [74] [75] [76] [77] . . Total fat mass is positively associated with an increased risk of knee cartilage defects, the presence of BMLs in healthy individuals aged 25-60 years 79 and medial tibiofemoral cartilage volume loss over 2-10 years in adults aged 51-81 years 80, 81 . A high waist-to-height ratio or waist circumference (indicative of abdominal adiposity) is associated with an increased risk of OA progression in the hand 82 ; however, neither outcome is associated with the longitudinal loss of tibial or patellar cartilage volume or defects in adults (aged 50-79 years) in the community 74, 83 . To better understand this relationship, a distinction between subcutaneous and visceral adiposity using valid assessment techniques, such as MRI or CT, is probably needed.
Physical activity is a modifiable outcome that might delay the onset of functional limitation and prevent obesity, and is essential for normal joint health 84 . In addition, physical activity can reduce pain and disability among individuals with OA and increase their physical performance and self-efficacy [85] [86] [87] . Low-intensity or moderate-intensity physical activity might protect against the onset of disability related to symptomatic OA, whereas a sedentary lifestyle or high levels of strenuous physical activity are considered risk factors [88] [89] [90] . Many variations of self-reported measures of physical activity exist, including global or short recall questionnaires, although most measures have limited accuracy [88] [89] [90] . Wearable monitors that measure body motion can be used to assess physical activity and energy expenditure. The most commonly used sensor, validated across multiple populations, is an accelerometer (for example, the ActiGraph accelerometer GT3X) 91 , which captures frequency, intensity and duration of physical activity in a time-stamped manner. By comparison, the large selection of off-the-shelf accelerometers, often contained in smart phones, might be more suitable for measuring physical activity in the primary-care setting as they are less expensive, easier to use and widely available 92, 93 . However, most accelerometers are not validated for measuring cycling or swimming. In general, objective measures of physical activity such as measures captured by an accelerometer have stronger relationships with function in OA than self-reported outcomes 94 and provide a more accurate assessment of physical activity and sedentary lifestyle.
Nutrition interventions, such as weight loss 95, 96 , are lifestyle-related changes that can potentially improve OA symptoms. Beyond the link between obesity and knee OA (and therefore the important contribution of weight loss) 97, 98 , the contribution of nutritional factors is an emerging and important area of research, although limited clinical evidence is available to date. For example, low dietary intake of fibre 99 or omega-3 polyunsaturated fatty acids 100 and high-fat diets 101 are risk factors for OA and/or worsening of pain in OA and might therefore warrant monitoring in early OA. Many of the nutrients or dietary patterns tested to date probably contribute to pathology via alterations in body weight or inflammation, although the direct effects of these factors requires further investigation. The tools to monitor dietary intake are numerous, and their appropriateness for each clinical or research setting needs to be assessed. They include the Food Frequency Questionnaire, the 24-hour dietary recall assessment tools (using either paper-based or web-based automated self-administered 24-hour dietary recall) 102 and the 3-day or 7-day weighed food record. The use of tools that assess adherence to diets that reduce inflammation, such as the Mediterranean Diet Adherence Screener 103 , might also be warranted in the future.
Hence, objective measures of adiposity are desirable. BMI is a useful outcome measure for assessing adiposity in the primary-clinical setting because of its familiarity, validity and reference ranges. However, BMI has limitations for use in young athletes. Although weight loss can improve OA symptoms, further research is needed to identify a means of assessing important OA-related nutritional factors. Assessment of physical activity using a validated accelerometer, to accurately capture activity through each domain and intensity, is a promising area that requires further study.
Biomechanical outcomes
Biomechanical outcomes are readouts of joint mechanics (such as joint movement, loading or muscle activation patterns) that are typically measured in the research setting but can sometimes also be measured in the primary-care setting.
Measures of joint mechanics can be employed to assess OA severity, but also to investigate the causes of OA onset and progression. For example, altered joint mechanics following knee injury might contribute to the onset and development of post-traumatic OA 38 . Indirect evidence to support this concept comes from observations of altered joint movement, loading and muscle activation patterns following injury [104] [105] [106] [107] [108] [109] , with radiographic knee OA (KL grade of ≥2) [110] [111] [112] , with ageing 113, 114 and following joint arthroplasty [115] [116] [117] . Abnormal joint alignment 118, 119 , alteration in the external knee adduction moment and increased varus alignment are often regarded as indicators of altered joint mechanics associated with increased OA severity 112 . Additional risk factors for the development of OA include aberrant dynamic joint stability 120, 121 , muscle atrophy 122 , neuromuscular inhibition 123 , muscle weakness [124] [125] [126] and compensatory muscle activation mechanisms 110, 111, 116 . These changes might alter cartilage loading and contact mechanics. Indeed, some studies have indicated that changes in tibiofemoral cartilage contact locations 38, 127 , elongated path lengths 128 , force magnitudes 105, 129, 130 and deformations 127, 128 are associated with OA onset and progression. In turn, OA progression might be caused by progressive degradation of cartilage through interactions of articular movement and cartilage loading abnormalities, chronic inflammation, resultant tissue remodelling and other OA risk factors by increasing the susceptibility of cartilage and subchondral bone to damage and degradation in regions inadequately adapted to these altered loads 127, [131] [132] [133] [134] [135] . Over time, this process might result in altered cartilage thickness and clinically relevant cartilage thinning in different regions of the articular cartilage surfaces. To verify this mechanism, longitudinal data on joint mechanics, cartilage thickness, and cartilage structure and integrity in OA are needed 136, 137 . Integration of this information with other risk factors for OA-related changes might inform the development of novel patient-specific, diagnostic or predictive models to aid in early patient screening, intervention efficacy monitoring and the development of new therapeutics 129, 130, 132, 138, 139 . Armed with these data and models, new wearable monitors might enable biomechanical outcome assessment in the clinic and community [133] [134] [135] 140, 141 , and might provide the possibility of developing and monitoring personalized treatment plans.
Measuring the range of motion of a joint might help in the assessment of OA severity in the primary-care setting. Although other biomechanical outcome measures (such as measures of knee adduction moment, joint kinematics and cartilage loading) are currently not feasible to collect in most clinical settings, they can be employed to help understand the mechanisms of OA progression and are an important consideration in the research setting to inform the design of orthotics and exercise, bracing and surgical interventions. In the future, validated wearable monitors might help to assess biomechanical outcomes of early interventions in the clinic and community. Evidence suggests that variation in one outcome measure (for example, a biomechanical outcome) is not independent but rather can influence variations in the quantitative state of other measures (for example, biochemical markers or imaging features) [142] [143] [144] [145] [146] . Thus, future research should consider the interaction between different outcome measures to potentially increase the sensitivity of detecting early OA 131, 143 .
Imaging features
OA is a complex syndrome that at the local level is best characterized as a whole-joint disease involving multiple tissue pathologies. To characterize and monitor the various structural components involved in OA, a number of different imaging modalities have been used, the most common being radiography, ultrasonography and MRI. This section predominantly focuses on plain radiography and MRI, as ultrasonography has several limitations that have constrained its development and validity in this area, including observer dependency and its inability to assess BMLs and to adequately image deep articular joint structures (including the meniscus and cartilage) 147 .
MRI has an important function in the OA research setting, with compositional MRI techniques becoming increasingly important owing to their capacity to assess 'pre-morphological' biochemical compositional changes of articular and periarticular tissues. Although radiography remains the primary imaging modality in OA clinical trials and in daily medical practice, known limitations for visualizing OA features notably limit the utility of radiography both clinically and in the research arena. Ultrasonography can be a useful adjunct to radiography and MRI, particularly for the evaluation of synovitis. Emerging hybrid imaging techniques, including PET-MRI and PET-CT, enable simultaneous evaluation of the joint and assessment of morphological changes and metabolic activities; these hybrid systems might have an increasing role in OA research and clinical practice in the future 148 . Radiographic features of OA are generally classified using the KL grading system 149 and include joint space narrowing, osteophyte formation, sclerosis and deformity of bony contours 150 . Minimum radiographic joint space width is the gold standard recommended by the FDA for detecting structural changes in patients with knee OA in clinical trials. However, standardized measures of radiographic positioning and fixed location joint space width does not reach the same degree of responsiveness (sensitivity to change) in knee OA as quantitative measures of cartilage thickness on MRI 151 . Moreover, radiographic features such as loss of joint space, sclerosis and deformity of bone are associated with late-stage OA and are detected earlier and with greater sensitivity by MRI 152 . Conventional MRI enables the evaluation of morphological changes related to early OA, including but not limited to cartilage damage, meniscal damage, synovitis, the presence of BMLs and ligamentous damage. In one study of 255 patients with knee pain (aged 40-79 years), BMLs were present in 11% of individuals without radiographic OA (KL grade 0), 38% of individuals with pre-radiographic OA (KL grade 1) and 71% of individuals with radiographic OA (KL grade of ≥2) 152, 153 . Similarly, 42% of patients with a diagnosis of symptomatic OA without radiographic features (KL grade of <2) had BMLs and 57% had cartilage loss 154 . Although there is a paucity of data regarding the timeline of structural changes in the period between a joint injury sustained in youth and the onset of clinical post-traumatic OA, advanced MRI techniques have been used to detect subtle cartilage damage at the time of ACL injury 155 . Furthermore, macroscopic cartilaginous changes, the presence of BMLs and bone morphological changes might be detectable by conventional MRI techniques as early as 2 years after ACL reconstruction or other intra-articular knee injury, and potentially before the development of radiographic OA 6, [156] [157] [158] [159] . In 2011, a definition of the criteria for the identification of OA on MRI was proposed to facilitate earlier detection of OA 160, 161 (Box 2).
In one study of patients who had undergone ACL reconstruction, 19% and 17% of the patients met the MRI criteria for tibiofemoral and patellofemoral OA, respectively, at 1 year 162 . Using the same criteria for MRI-defined OA in patients who participated in a clinical trial of ACL reconstruction, 31% of the patients had tibiofemoral OA and 9% had patellofemoral OA at 5 years 163 . Importantly, some of the changes included in these criteria are undetectable by radiography (such as cartilage thickness and BMLs). Different methodologies can be used to measure structural changes in the knee by MRI including the use of semi-quantitative measures (using scoring systems such as the MRI Osteoarthritis Knee Score (MOAKS) and the Anterior Cruciate Ligament Osteoarthritis Score (ACLOAS) 153, 164 ), quantitative measures (including measures of cartilage thickness, BML volume, effusion-synovitis volume and meniscal extrusion) and measures obtained using compositional imaging modalities (including T2 mapping, T1ρ mapping, delayed gadolinium-enhanced MRI of cartilage (dGEMRIC), sodium MRI and glycosaminoglycan chemical exchange saturation transfer (gagCEST)), which measure cartilage composition and quality 165 . 168, 169 . Ultimately, the association between the presence of these findings on MRI and subsequent illness related to OA (alteration in patient function and symptoms) needs to be identified in longitudinal follow-up studies 170 to avoid over-diagnosis because of incidental MRI findings 152, 153, [171] [172] [173] . Notably, the distinction between pathology and normal features of the ageing joint is unclear, and further research to elucidate the clinical relevance of MRI findings in early knee OA is warranted.
Hence, the utility of plain radiography in early OA is limited, as only relatively late OA changes are detectable. As technology improves, assessing changes in bone shape or trabecular bone texture of subchondral bone might be of use. MRI has superior validity and sensitivity to change in the context of early OA 152 . Although not appropriate for all primary-care settings because of its high cost and risk of over-diagnosis, MRI is a critical component of ongoing outcome validation research in early knee OA.
Biochemical marker outcomes
Biochemical markers of joint tissue turnover can reflect disease-relevant biological activity that might precede structural changes detectable on plain radiographs or even on MRI scans. Some biochemical markers detected in the blood, urine or synovial fluid might be associated with, or predictive of, incident radiographic OA. Ideally, biochemical markers of early OA must clearly differentiate between normal (physiological) and pathological tissue turnover, as well as between the early stages of the disease and more advanced joint destruction. For clinical utility, biochemical markers must also be unaffected by other disorders and be easily and consistently measurable in the clinical setting 174 . Biochemical markers of early OA might be used to identify pre-radiographic changes at the molecular level, facilitate OA drug discovery and potentially enable a more rational and personalized approach to health-care-related OA management by prompting earlier and more targeted treatments and interventions 175 . Studies of incident OA have identified some of the earliest molecular abnormalities associated with OA and have therefore provided biochemical marker candidates for early OA identification. For example, in a retrospective nested case-control study, the serum concentrations of four proteins (matrix metalloproteinase 7, IL-15, plasminogen activator inhibitor 1 and soluble vascular adhesion protein 1) were altered in individuals who later developed OA compared with individuals who remained healthy 176 . Similarly, in other studies, high serum concentrations of cartilage oligomeric matrix protein (COMP) and hyaluronan predicted incident knee joint space narrowing and osteophyte formation (COMP only) 7 years later 177 , whereas high serum concentrations of COMP or low serum concentrations of aggrecan predicted incident radiographic knee OA over 10 years 178 . By contrast, the concentrations of other molecular biomarkers of inflammation (including IL-6, IL-8, IL-10, TNF and IFNγ in the serum and synovial fluid) in individuals 2 years after an acute ACL injury did not predict the development of structural knee OA at 5 years 163 . Furthermore, mean baseline serum concentrations of osteocalcin were associated with 3-year incident radiographic hand OA (KL grade of ≥2) but not with knee OA in premenopausal and perimenopausal women 179 . Other potential biochemical markers include bioactive lipids (such as low-density lipoprotein, cholesterol and eicosanoids, including hydroxyeicosatetraenoic acid and its derivatives) as markers of pain and inflammation 180 , and metabolic profiles, which have been shown to differ in the synovium between patients with OA and healthy individuals 181 . In 2006, the US NIH-funded OA Biomarkers Network and the OARSI Clinical Trials Biomarkers Working Group proposed a new classification system for OA biochemical markers termed BIPED (burden of disease, investigative, prognostic, efficacy of intervention and diagnostic) 182, 183 . The purpose of this classification was to clarify the intended primary use of a biochemical marker 182, 183 . However, a systematic review performed in 2010 concluded that individual biochemical markers and categories of biochemical markers for knee and hip OA, including their nature, origin and metabolism, need further investigation and validation 184 . In 2016, the BEST glossary designed by the FDA-NIH Biomarker Working Group to harmonize and clarify terms used in translational research was published 185 . Harmonization of these terms is important as their inconsistent use can hinder the evaluation and interpretation of scientific evidence.
One of the aims of the BEST resource is to distinguish between biochemical markers and clinical assessments and to describe the distinct functions of biochemical markers in biomedical research, clinical practice and medical product development. This glossary should facilitate all aspects of biochemical marker research, including the testing, validation and commercialization of biochemical markers of early OA.
Biochemical and molecular profiling of biological fluids and joint tissues can provide a global view of the physiological state of an OA joint. Refinements in omics approaches and advances in analytical platforms and technologies should enable improved profiling of different stages of disease. To be clinically useful, biochemical markers need to be properly qualified (that is, the biochemical marker should be linked with a biomechanical and/or clinical outcome) for early OA, and they must adhere to the BEST guidelines to be effectively used in the clinical setting rather than in an exploratory and hypothesis-testing research setting. Soluble biochemical markers require further study, validation and qualification as markers of susceptibility to, or risk of, early OA before being adopted for widespread use in the clinical care setting.
Conclusions
There are various outcome domains that can be assessed in patients with early knee OA in research and/or clinical settings, including patient-reported outcomes, clinical features, physical function outcomes, modifiable lifestyle-related outcomes (such as adiposity, physical activity and nutrition), biomechanical outcomes, imaging features and biochemical markers. Promising patient-reported outcome measures for this purpose include the KOOS and the ICOAP questionnaire. Physical function outcome measures (for example, the single leg hop test and measures of quadriceps strength) and the fat mass index are also valid and reliable. With increasing popularity worldwide, validated wearable physical activity monitors for quantifying levels of physical activity and a 3-day weighed food record for nutritional intake (for example, calorie intake) have potential. MRI-defined OA and biochemical markers, although promising, require specific health-care and research facilities where the assessment of these outcomes is possible and body fluids can be collected, stored and measured according to standard operating procedures. Patient preferences and psychosocial outcomes are also important considerations in future research examining early knee OA outcome measures 186 . In this regard, further patient-engaged research is recommended.
Importantly, multiple factors must be considered to facilitate risk assessment and the development of predictive models for early knee OA. Furthermore, definitions are needed for the potential outcomes, exposures, confounding and effect-modifying variables, duration of the clinically relevant prediction period and the setting in which the risk prediction tool will be used. As such, further research validating outcomes in individuals 'at risk' of early OA progression (for example, individuals with an intra-articular knee injury and/or who are obese) and in those with early OA is required.
